vimarsana.com

Page 276 - இந்தியன் நிறுவனம் ஆஃப் தொழில்நுட்பம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sunita Badola: Heading External Partnerships and Patient Data Strategy at Global Giant Takeda Pharmaceuticals

INDIA New England News Sunita Badola BOSTON- A leader in the New England biotechnology and pharmaceuticals cluster, Sunita Badola is the Head of External Partnership and Patient Data Strategy, in the Global R&D Computational Biology group at Takeda Pharmaceuticals in Cambridge, MA. She has a strong record of scientific innovation and building partnerships in drug discovery, translational research and data sciences with more than 22 years of experience in the biopharmaceutical industry. She has been leading external strategy of human data utilization across therapeutic areas and key diseases of focus such as Oncology. Ms. Badola has extensive experience in translational research, applied genomics, data infrastructure/analytics and establishing key partnerships for innovative technologies to advance clinical biomarker development.

The Emergence of 2 5D Custom SoCs and Chiplets in AI and HPC Applications

The Emergence of 2.5D Custom SoCs and Chiplets in AI and HPC Applications Webinar Overview 2021 promises to be the breakthrough year when 2.5D based custom SoCs and chiplets will play a very prominent role in turbo-charging cloud/AI, HPC, networking and storage applications. Join us for this webinar to learn more about how OpenFive is collaborating with our customers and partners to drive domain-specific innovations in Die-to-Die (D2D) IP, custom silicon and advanced package design methodologies. Key Learnings: Who Should Attend?: Speaker VP, Product & Corporate Marketing Sudhir Mallya is Vice President of Corporate and Product Marketing. He is responsible for custom silicon product marketing, technology roadmaps and business model innovation, corporate marketing initiatives, and strategic customer and partner alliances. He was previously at Toshiba where he led their North American silicon BU with a focus on data center and automotive applications. He is based in Silicon Val

IIT Madras Researchers Study Could Pave The Way For Development Of Effective Drugs To Treat HIV-AIDS

IIT Madras researchers find new method to make AIDS drug more effective

IIT Madras researchers find new method to make AIDS drug more effective The findings of their study, published in Biochemistry, the peer-review Journal of the American Chemical Society, say that introducing electrostatic interaction sites on potential drug molecules can enhance the efficacy of the antiviral drug against the HIV virus Joe C Mathew | February 18, 2021 | Updated 14:15 IST IIT Madras (Image: PTI) Researchers at the Indian Institute of Technology, Madras claim to have found a novel way to make HIV/AIDS drugs more effective. The findings of their study, published in Biochemistry, the peer-review Journal of the American Chemical Society, say that introducing electrostatic interaction sites on potential drug molecules can enhance the efficacy of the antiviral drug against the HIV virus. The research was led by Prof. Sanjib Senapati, Department of Biotechnology, IIT Madras, along with research scholars Mohammed Ahsan and Chinmai Pindi.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.